These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 20367795

  • 1. Four-year study of lamivudine and adefovir combination therapy in lamivudine-resistant hepatitis B patients: influence of hepatitis B virus genotype and resistance mutation pattern.
    Inoue J, Ueno Y, Wakui Y, Niitsuma H, Fukushima K, Yamagiwa Y, Shiina M, Kondo Y, Kakazu E, Tamai K, Obara N, Iwasaki T, Shimosegawa T.
    J Viral Hepat; 2011 Mar; 18(3):206-15. PubMed ID: 20367795
    [Abstract] [Full Text] [Related]

  • 2. Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B.
    Santantonio T, Fasano M, Durantel S, Barraud L, Heichen M, Guastadisegni A, Pastore G, Zoulim F.
    Antivir Ther; 2009 Mar; 14(4):557-65. PubMed ID: 19578241
    [Abstract] [Full Text] [Related]

  • 3. Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants.
    Chen CH, Wang JH, Lu SN, Hu TH, Hung CH, Chang MH, Changchien CS, Lee CM.
    Antivir Ther; 2012 Mar; 17(4):701-9. PubMed ID: 22358132
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O, Benhamou Y, Cahour A, Katlama C, Poynard T, Thibault V.
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [Abstract] [Full Text] [Related]

  • 7. Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy.
    Kim SS, Cho SW, Kim SO, Hong SP, Cheong JY.
    J Med Virol; 2013 Jan; 85(1):55-64. PubMed ID: 23096938
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.
    Brunelle MN, Jacquard AC, Pichoud C, Durantel D, Carrouée-Durantel S, Villeneuve JP, Trépo C, Zoulim F.
    Hepatology; 2005 Jun; 41(6):1391-8. PubMed ID: 15915463
    [Abstract] [Full Text] [Related]

  • 9. Rescue therapy for lamivudine-resistant chronic hepatitis B: comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy.
    Kim HJ, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI.
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1374-80. PubMed ID: 20659226
    [Abstract] [Full Text] [Related]

  • 10. Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B.
    Dai CY, Chuang WL, Hsieh MY, Lee LP, Huang JF, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML.
    Antiviral Res; 2007 Aug; 75(2):146-51. PubMed ID: 17400303
    [Abstract] [Full Text] [Related]

  • 11. Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir.
    Karatayli E, Idilman R, Karatayli SC, Cevik E, Yakut M, Seven G, Kabaçam G, Bozdayi AM, Yurdaydin C.
    Antivir Ther; 2013 Aug; 18(1):77-85. PubMed ID: 22878399
    [Abstract] [Full Text] [Related]

  • 12. Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir.
    Choe WH, Hong SP, Kim BK, Ko SY, Jung YK, Kim JH, Yeon JE, Byun KS, Kim KH, Ji SI, Kim SO, Lee CH, Kwon SY.
    Antivir Ther; 2009 Aug; 14(7):985-93. PubMed ID: 19918102
    [Abstract] [Full Text] [Related]

  • 13. Virological response and incidence of adefovir resistance in lamivudine-resistant patients treated with adefovir dipivoxil.
    Chen CH, Wang JH, Lee CM, Hung CH, Hu TH, Wang JC, Lu SN, Changchien CS.
    Antivir Ther; 2006 Aug; 11(6):771-8. PubMed ID: 17310821
    [Abstract] [Full Text] [Related]

  • 14. Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir.
    Heo NY, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    J Hepatol; 2010 Sep; 53(3):449-54. PubMed ID: 20646776
    [Abstract] [Full Text] [Related]

  • 15. Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.
    Yatsuji H, Suzuki F, Sezaki H, Akuta N, Suzuki Y, Kawamura Y, Hosaka T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Watahiki S, Iwasaki S, Kobayashi M, Kumada H.
    J Hepatol; 2008 Jun; 48(6):923-31. PubMed ID: 18433925
    [Abstract] [Full Text] [Related]

  • 16. Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.
    van Bömmel F, Zöllner B, Sarrazin C, Spengler U, Hüppe D, Möller B, Feucht HH, Wiedenmann B, Berg T.
    Hepatology; 2006 Aug; 44(2):318-25. PubMed ID: 16871563
    [Abstract] [Full Text] [Related]

  • 17. Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.
    Vassiliadis TG, Giouleme O, Koumerkeridis G, Koumaras H, Tziomalos K, Patsiaoura K, Grammatikos N, Mpoumponaris A, Gkisakis D, Theodoropoulos K, Panderi A, Katsinelos P, Eugenidis N.
    J Gastroenterol Hepatol; 2010 Jan; 25(1):54-60. PubMed ID: 19780875
    [Abstract] [Full Text] [Related]

  • 18. Adefovir for chronic hepatitis B treatment: identification of virological markers linked to therapy response.
    Rodriguez-Frias F, Jardi R, Schaper M, Buti M, Ferrer-Costa C, Tabernero D, Homs M, Esteban R.
    Antivir Ther; 2008 Jan; 13(8):991-9. PubMed ID: 19195324
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
    Lee YS, Chung YH, Kim JA, Kim SE, Shin JW, Kim KM, Lim YS, Park NH, Lee HC, Lee YS, Suh DJ.
    Liver Int; 2009 Apr; 29(4):552-6. PubMed ID: 19323782
    [Abstract] [Full Text] [Related]

  • 20. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.
    Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, Chung YH, Lee YS, Yoo W, Kim SO.
    Hepatology; 2006 Jun; 43(6):1385-91. PubMed ID: 16729316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.